Kalmomi 10 da Ya Kamata Ku sani: smallananan Lwayar Cutar Sanyin Ciki

Wadatacce

• Shirya mutuwa-ligand 1 (PD-L1)
• Mai karɓa mai haɓaka Epidermal factor (EGFR)
• T790M maye gurbi
• Tyrosinse-kinase inhibitor (TKI) far
• KRAS maye gurbi
• Canjin maye gurbin lymphoma kinase (ALK)
• Adenocarcinoma
• Kwayar squamous (epidermoid) carcinoma
• Babban cell (ba a rarrabe shi) carcinoma
• Immunotherapy

Bayani

Ko an gano ku ko ƙaunataccen ku, ƙananan ƙananan ƙwayoyin cuta na huhu (NSCLC) da kuma kalmomin da yawa da suka danganta da shi na iya zama abin mamayewa. Ingoƙarin kiyaye duk kalmomin da likitanku ya gaya muku na iya zama da wahala, musamman ban da tasirin motsin rai na kansar.

Anan ga kalmomi 10 don sani game da NSCLC wanda zaku iya cin karo dashi yayin da kuke yin hanyarku ta hanyar gwaji da magani.

Shirya mutuwa-ligand 1 (PD-L1)

Gwajin PD-L1 yana auna ingancin wasu hanyoyin kwantar da hankali (yawanci masu sassaucin ra'ayi) ga waɗanda ke tare da NSCLC. Wannan yana taimaka wa likitocin bayar da shawarar mafi kyawun zaɓin magani na biyu.

Koma zuwa banki kalma

Mai karɓa mai haɓaka Epidermal factor (EGFR)

EGFR wani jinsi ne wanda ke cikin ci gaban kwayar halitta da rarrabuwa. Maye gurbi na wannan kwayar halitta yana da alaƙa da ciwon huhu na huhu. Har zuwa rabin dukkan cututtukan daji na huhu suna da maye gurbi.

Koma zuwa banki kalma

T790M maye gurbi

T790M shine maye gurbin EGFR wanda aka gani a kusan rabin duk shari'o'in NSCLC masu tsayayya da ƙwayoyi. Maye gurbi yana nufin akwai canji a cikin amino acid, kuma yana shafar yadda wani zai amsa maganin.

Koma zuwa banki kalma

Tyrosinse-kinase inhibitor (TKI) far

Maganin TKI wani nau'in magani ne wanda aka niyya ga NSCLC wanda ke toshe ayyukan EGFR, wanda zai iya hana ƙwayoyin cutar kansa girma.

Koma zuwa banki kalma

KRAS maye gurbi

Kwayar KRAS tana taimakawa daidaita rabe-raben sel. Wani bangare ne na rukunin kwayoyin halittar da ake kira oncogenes. A yanayin maye gurbi, yana iya juya lafiyayyun kwayoyin halitta zuwa na masu cutar kansa. Ana ganin maye gurbi na KRAS a kusan kashi 15 zuwa 25 na duk cututtukan daji na huhu.

Koma zuwa banki kalma

Canjin maye gurbin lymphoma kinase (ALK)

Canjin ALK shine sake tsara fasalin tsarin ALK. Wannan maye gurbi yana faruwa kusan kashi 5 cikin ɗari na al'amuran NSCLC, galibi galibi a cikin waɗanda ke da nau'in adenocarcinoma na NSCLC. Maye gurbi na haifar da kwayar cutar kansa ta huhu girma da bazuwa.

Koma zuwa banki kalma

Adenocarcinoma

Adenocarcinoma yanki ne na NSCLC. Yana da saurin girma fiye da sauran nau'o'in ciwon huhu na huhu, amma wannan ya bambanta. Wannan shine nau'in cutar sankarar huhu da aka fi sani da masu shan sigari.

Koma zuwa banki kalma

Kwayar squamous (epidermoid) carcinoma

Amananan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta ta NSCLC. Mutane da yawa da ke da wannan nau'in ƙwayar cutar huhu suna da tarihin shan sigari. Ciwon kansa yana farawa a cikin ƙwayoyin ƙwayoyin cuta, waɗanda sune ƙwayoyin dake cikin huhun iska.

Koma zuwa banki kalma

Babban cell (ba a rarrabe shi) carcinoma

Babban ƙwayar carcinoma ƙananan nau'in NSCLC ne wanda zai iya bayyana a kowane ɓangare na huhu. Yawanci yana da wuyar magani saboda yana girma kuma yana yaɗuwa da sauri. Yana da kimanin kashi 10 zuwa 15 na cututtukan huhu.

Koma zuwa banki kalma

Immunotherapy

Immunotherapy wani sabon magani ne na cutar kansa wanda ke amfani da garkuwar jikin mutum don taimakawa jiki kai hari kan ƙwayoyin kansa. Ana iya amfani dashi don magance wasu nau'ikan NSCLC, musamman ga mutanen da cutar kansa ta dawo bayan magani ko wani magani.

Koma zuwa banki kalma